clinical trial · NCT07633171
Multimodal Glucose Prediction in Type 2 Diabetes
Type 2 DiabetesDigital Health Data Collection System
brief summary
The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.
started
Jun 15, 2026
primary completion
Jan 15, 2027
completion
Feb 26, 2027
last updated
Jun 9, 2026
official title
CGM- and Behavior-based Large Health Model for Just-in-time Diabetes Management
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol